Jason Shafrin, PhD, discusses a recent paper which reviewed publicly available data on performance-based risk sharing agreements for medical devices and diagnostics.
Jason Shafrin, PhD, discusses a recent paper which reviewed publicly available data on performance-based risk sharing agreements for medical devices and diagnostics.
Jason Shafrin, PhD, discusses a report from the Health Care Payment Learning and Action Network which assessed whether alternative payment models have gained market share from 2019 to 2020.
Jason Shafrin, PhD, discusses a report from the Health Care Payment Learning and Action Network which assessed whether alternative payment models have gained market share from 2019 to 2020.
Jason Shafrin, PhD, discusses a paper examining how prices vary for branded, physician-administered drugs which had generic or biosimilar versions introduced before 2005.
Jason Shafrin, PhD, discusses a paper examining how prices vary for branded, physician-administered drugs which had generic or biosimilar versions introduced before 2005.
Jason Shafrin, PhD, discusses a survey which explored affordability challenges posed by orphan drugs from the payer, provider, and employer perspectives.
Jason Shafrin, PhD, discusses a survey which explored affordability challenges posed by orphan drugs from the payer, provider, and employer perspectives.
Jason Shafrin, PhD, highlights the Patient-Centered Outcomes Research Institute's (PCORI) Proposed “Principles” for the Consideration of the Full Range of Outcomes Data.
Jason Shafrin, PhD, highlights the Patient-Centered Outcomes Research Institute's (PCORI) Proposed “Principles” for the Consideration of the Full Range of Outcomes Data.
Jason Shafrin, PhD, highlights a study noting that value assessment is not a one-time endeavor but needs to be revisited as a treatment landscape evolves.
Jason Shafrin, PhD, highlights a study noting that value assessment is not a one-time endeavor but needs to be revisited as a treatment landscape evolves.
Jason Shafrin, PhD, is a Director and Senior Research Economist at Precision Health Economics (PHE) in Los Angeles as well as the Director of Research at the Innovation and Value Initiative (IVI). The opinions expressed on this blog are only Jason’s and do not represent the opinions of PHE in any way.
Jason’s research interests include all issues related to healthcare policy and economics, value-based purchasing, the health insurance market, and Medicare policy research. For up to date information regarding Jason’s most recent research and contact information, please visit his homepage. You can view his published work on his Google Scholar page. Jason’s research has been published in a variety of peer-reviewed journals including JAMA, Health Affairs, Health Economics, Health Services Research, Value in Health, American Journal of Cardiology among others. In popular media, Dr. Shafrin has been interviewed by National Public Ratio (NPR), the Washington Times, and various trade journals and also has written articles for Forbes, the Health Affairs blog, STAT News, US News and World Report, and the Washington Post, among others.
